Home › Funds › UBS Group AG › FATE
UBS Group AG position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)590.18K sh
Reported value held$1.59M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 26.48K | $1.57M | New |
| Q4 2021 | 128.00K | $7.49M | Add |
| Q1 2022 | 139.51K | $5.41M | Add |
| Q2 2022 | 52.49K | $1.30M | Reduce |
| Q3 2022 | 2.37K | $53.00K | Reduce |
| Q4 2022 | 291.91K | $2.95M | Add |
| Q1 2023 | 418.13K | $2.38M | Add |
| Q2 2023 | 259.69K | $1.24M | Reduce |
| Q3 2023 | 66.71K | $141.43K | Reduce |
| Q4 2023 | 176.31K | $659.38K | Add |
| Q1 2024 | 444.05K | $3.26M | Add |
| Q2 2024 | 164.36K | $539.09K | Reduce |
| Q3 2024 | 404.28K | $1.41M | Add |
| Q4 2024 | 1.10M | $1.82M | Add |
| Q1 2025 | 1.55M | $1.23M | Add |
| Q2 2025 | 962.67K | $1.08M | Reduce |
| Q3 2025 | 314.76K | $396.60K | Reduce |
| Q4 2025 | 403.52K | $396.66K | Add |
| Q1 2026 | 1.82M | $2.19M | Add |
| Q2 2026 | 590.18K | $1.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- AQR Capital Management 3.84M sh · $10.36M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026